fPSA Rapid Quantitative Test

PSA, a protein produced by prostate gland cells, circulates through the body in two ways: either bound to other proteins or on its own. PSA traveling alone is called free PSA. The free-PSA test measures the percentage of unbound PSA.

2 in 1 (CEA/AFP) Rapid Quantitative Test

Biotime 2 in 1 (CEA/AFP) test kit has very important guiding significance in the diagnosis of liver cancer and can improve the accuracy of clinical diagnosis.

AFP Rapid Quantitative Test

Alpha-fetoprotein (AFP) is a protein produced primarily by the liver in a developing baby (fetus) and the portion of a developing embryo that is similar to the yolk cavity in bird eggs (yolk sac tissues). AFP levels are typically elevated when a baby is born and then decline rapidly.

CEA Rapid Quantitative Test

Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.

tPSA Rapid Quantitative Test

Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood.

2 in 1(CRP/SAA) Rapid Quantitative Test

Biotime 2 in 1 test kit can help the operator to distinguish the bacterial infection and viral infection, and improve the accuracy of clinical diagnosis of infectious diseases.

Lp-PLA2 Rapid Quantitative Test

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that plays a role in the inflammation of blood vessels and is thought to help promote atherosclerosis. Biotime rapid quantitative test kit measures the amount or activity of Lp-PLA2 in the human blood.

HCY Rapid Quantitative Test

Homocysteine, often shortened to HCY, is a thiol containing amino acid produced by the intracellular demethylation of methionine. Excess HCY in the bloodstream may cause injuries to arterial vessels due to its irritant nature and result in inflammation and plaque formation, which may eventually cause a blockage of blood flow to the heart.

Myo Rapid Quantitative Test

Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.

Specimen Types	Serum
Specimen Capacity	20μL
Reaction Time	15 min
Sample Capacity	80μL
Detection Range	0.2-30ng/mL

Fluorescence Immunoassay

Tumor Marker

fPSA Rapid Quantitative Test